Picodya

Picodya is an innovative company based in Rehovot, Israel, founded in 2018. It specializes in advanced in vitro diagnostics (IVD) technology aimed at enhancing accessibility and mass deployment at the point of care. The company’s mission is to improve global diagnostics access through its proprietary pico-fluidics technology, which utilizes small reagent volumes to deliver rapid and high-quality diagnostic results. The flagship product, the B-Matrix™ platform, is a fully automated diagnostic system capable of processing up to 120 assays per hour. It combines immunoassays and molecular assays, enabling quick turnaround times for syndromic testing panels. Picodya also offers disposable cartridges and single-use assay kits that facilitate versatile testing across various bodily fluids. The company serves healthcare providers, including hospitals, clinics, and research institutions, by providing rapid and reliable diagnostic solutions that support efficient clinical decision-making. With approximately $10 million in funding and a small team, Picodya is focused on expanding access to high-quality diagnostics worldwide.

• Employees 31
• Founded 2018
• Total Funding $10000000